Loading CHRS charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading CHRS comparable companies…
| CHRSCoherus Oncology, Inc.(opens in a new tab) | $0.13B | $0.05B | +61.0% | 68.9% | −311.6% | 2.53× | — |
|---|---|---|---|---|---|---|---|
| RXRXRecursion Pharmaceuticals, Inc.(opens in a new tab) | $2.14B | $0.05B | −15.1% | 3.5% | −991.7% | 39.07× | — |
| EDITEditas Medicine, Inc.(opens in a new tab) | $0.32B | $0.05B | +20.8% | — | −161.4% | 6.76× | — |
| STROSutro Biopharma, Inc.(opens in a new tab) | $0.15B | $0.05B | −56.3% | — | −319.6% | 3.30× | — |
| DTILPrecision Biosciences Inc.(opens in a new tab) | $0.18B | $0.05B | +3473.0% | — | −80.8% | 4.05× | — |
| Medianpeers, excl. CHRS | $0.25B | $0.05B | +2.9% | 3.5% | −240.5% | 5.40× | — |